IPMK
Inositol polyphosphate multikinase (EC 2.7.1.140) (EC 2.7.1.151) (EC 2.7.1.153) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase) [IMPK]
PublicationsПравить
Biogerontological research highlighted a complex and dynamic connection between aging, health and longevity, partially determined by genetic factors. Multifunctional proteins with moonlighting features, by integrating different cellular activities in the space and time, may explain part of this complexity. Inositol Polyphosphate Multikinase (IPMK) is a potential moonlighting protein performing multiple unrelated functions. Initially identified as a key enzyme for inositol phosphates synthesis, small messengers regulating many aspects of cell physiology, IPMK is now implicated in a number of metabolic pathways affecting the aging process. IPMK regulates basic transcription, telomere homeostasis, nutrient-sensing, metabolism and oxidative stress. Here, we tested the hypothesis that the genetic variability of [i]IPMK[/i] may affect human longevity. Single-SNP (single nuclear polymorphism), haplotype-based association tests as well as survival analysis pointed to the relevance of six out of fourteen genotyped SNPs for female longevity. In particular, haplotype analysis refined the association highlighting two SNPs, rs2790234 and rs6481383, as major contributing variants for longevity in women. Our work, the first to investigate the association between variants of [i]IPMK[/i] and longevity, supports [i]IPMK[/i] as a novel gender-specific genetic determinant of human longevity, playing a role in the complex network of genetic factors involved in human survival.
MeSH Terms
- Aged
- Aged, 80 and over
- Female
- Humans
- Longevity
- Male
- Middle Aged
- Phosphotransferases (Alcohol Group Acceptor)
- Polymorphism, Single Nucleotide
- Sex Factors
Keywords
- IPMK
- SNP
- aging
- gender-specific association
- inositol phosphates
- longevity
- moonlighting protein
- polymorphism
- survival